| 发明名称 |
Treatment regimens using anti-NKG2A antibodies |
| 摘要 |
The present invention relates to methods for the treatment of disease, notably cancer, using antibodies that specifically bind and inhibit human NKG2A. Included are therapeutic regimens that provide improved efficacy of anti-NKG2A antibodies. |
| 申请公布号 |
AU2015316993(A1) |
申请公布日期 |
2017.03.16 |
| 申请号 |
AU20150316993 |
申请日期 |
2015.09.15 |
| 申请人 |
Innate Pharma |
发明人 |
Andre, Pascale;Blery, Mathieu;Paturel, Carine;Soulas, Caroline;Wagtmann, Nicolai |
| 分类号 |
C07K16/28;A61K39/00;A61K39/395;A61P29/00;A61P35/00 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
